D-1695-2012 Class II Terminated
FDA drug recall D-1695-2012 was initiated by Abbott Laboratories on Jul 19, 2012 and is designated Class II. Reason for recall: Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets. The recall status is terminated (terminated Nov 1, 2013). Affected quantity: 42,596 Bottles.
Recall Details
- Product Type
- Drugs
- Report Date
- Oct 3, 2012
- Initiation Date
- Jul 19, 2012
- Termination Date
- Nov 1, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 42,596 Bottles
Product Description
Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chicago, IL 60064, NDC: 0074-5182-90.
Reason for Recall
Defective Container: A number of Synthroid bottles have a localized thin wall defect on the bottom which may potentially impact the stability of the tablets.
Distribution Pattern
Nationwide
Code Information
Lot: 18353A8, Exp 08/31/2013
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1695-2012
- openFDA file date
- Oct 27, 2026
- Loaded by RegDataLab
- Oct 29, 2026